{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:01:51Z","timestamp":1785315711823,"version":"3.55.0"},"reference-count":43,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Scientific Research Project for Higher Education Institutions in Henan Province","award":["26B310011"],"award-info":[{"award-number":["26B310011"]}]},{"name":"the Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences","award":["2026BP0101"],"award-info":[{"award-number":["2026BP0101"]}]},{"name":"the Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences","award":["2026BP0201"],"award-info":[{"award-number":["2026BP0201"]}]},{"name":"Key Scientific and Technological Project of Henan Province","award":["262102310156"],"award-info":[{"award-number":["262102310156"]}]},{"name":"Key Scientific and Technological Project of Henan Province","award":["252102310154"],"award-info":[{"award-number":["252102310154"]}]},{"name":"Key Scientific and Technological Project of Henan Province","award":["252102310300"],"award-info":[{"award-number":["252102310300"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) remains one of the most aggressive and lethal malignancies worldwide, with high rates of metastasis and recurrence contributing to its poor prognosis. There is an urgent need to elucidate the molecular mechanisms driving HCC progression and to develop effective therapeutic strategies. Metabolic reprogramming, especially aerobic glycolysis known as the Warburg effect, is a well-established hallmark of cancer. Concurrently, cancer stem cells (CSCs) play crucial roles in tumor initiation, therapy resistance, and recurrence. However, the involvement of long non-coding RNAs (lncRNAs) in linking metabolic alterations and stemness remains poorly understood. In this investigation, we identified LINC02041 as a significantly upregulated lncRNA in HCC tissues and demonstrated its oncogenic role in promoting cell proliferation. We found that STAT3 transcriptionally activates LINC02041 expression. Mechanistically, LINC02041 enhances the stability of SRSF1 protein by suppressing its ubiquitin-mediated degradation, thereby facilitating HCC cell proliferation, migration, glycolytic metabolism, and acquisition of stem-like properties. Our findings delineate a novel STAT3\/LINC02041\/SRSF1 regulatory axis that coordinately modulates glycolytic reprogramming and stemness maintenance in hepatocarcinogenesis. This study not only advances our understanding of HCC pathophysiology but also identifies LINC02041 as a promising prognostic biomarker and a compelling therapeutic target for novel therapeutic strategies against this aggressive malignancy.<\/jats:p>","DOI":"10.3390\/cells15151350","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:11:56Z","timestamp":1785168716000},"page":"1350","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The LINC02041\/SRSF1 Axis Facilitates Aerobic Glycolysis and Stemness Maintenance in Hepatocellular Carcinoma"],"prefix":"10.3390","volume":"15","author":[{"given":"Mingjiao","family":"Cheng","sequence":"first","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Cheng","sequence":"additional","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Li","sequence":"additional","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjiang","family":"He","sequence":"additional","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7965-3332","authenticated-orcid":false,"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7894-5408","authenticated-orcid":false,"given":"Weiwei","family":"Lin","sequence":"additional","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"},{"name":"Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou 450052, China"},{"name":"Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou 450052, China"},{"name":"National Key Laboratory of Metabolism Disorder and Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0798","authenticated-orcid":false,"given":"Fang","family":"Xu","sequence":"additional","affiliation":[{"name":"Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: Updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","first-page":"EVIDoa2100070","article-title":"Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma","volume":"1","author":"Lau","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strau\u00df, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., and Kossatz-Boehlert, U. (2020). Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01280"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yadav, D.K., Yadav, R.K., Singh, A., Huang, Y., Bao, D., Yang, Z., Huang, H., Jiang, Y., Wang, P., and Lin, S. (2025). Cancer stem cells in hepatocellular carcinoma: Therapy resistance and emerging treatments. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1704868"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/EBC20220001","article-title":"Mechanisms of resistance to tyrosine kinase inhibitors in liver cancer stem cells and potential therapeutic approaches","volume":"66","author":"Man","year":"2022","journal-title":"Essays Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.7150\/thno.54648","article-title":"Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma","volume":"11","author":"Dai","year":"2021","journal-title":"Theranostics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the Intersections between Metabolism and Cancer Biology","volume":"168","author":"DeBerardinis","year":"2017","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Alberghina, L. (2023). The Warburg Effect Explained: Integration of Enhanced Glycolysis with Heterogeneous Mitochondria to Promote Cancer Cell Proliferation. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115787"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yang, Y., Gao, Y., Xiong, Y., Gong, Y., Lu, J., Zhang, Y., Wang, D., Liu, Z., and Shi, X. (2024). Research Progress of Warburg Effect in Hepatocellular Carcinoma. Front. Biosci. (Landmark Ed.), 29.","DOI":"10.31083\/j.fbl2905178"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/jcmm.17687","article-title":"ASPP2 suppresses tumour growth and stemness characteristics in HCC by inhibiting Warburg effect via WNT\/\u03b2-catenin\/HK2 axis","volume":"27","author":"Liang","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","article-title":"Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1\u03b1\/PPAR-\u03b3\/PKM2-mediated glycolysis","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","article-title":"Small and long non-coding RNAs: Past, present, and future","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm.3981","article-title":"The emerging role of lncRNAs in cancer","volume":"21","author":"Huarte","year":"2015","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-10-38","article-title":"The functional role of long non-coding RNA in human carcinomas","volume":"10","author":"Gibb","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrm.2017.104","article-title":"The functions and unique features of long intergenic non-coding RNA","volume":"19","author":"Ransohoff","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional Classification and Experimental Dissection of Long Noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhang, X., Wang, W., Zhu, W., Dong, J., Cheng, Y., Yin, Z., and Shen, F. (2019). Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225573"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1038\/s41388-021-01908-0","article-title":"Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC","volume":"40","author":"Xu","year":"2021","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"108685","DOI":"10.1016\/j.biopha.2019.108685","article-title":"Depletion of the lncRNA RP11-567G11.1 inhibits pancreatic cancer progression","volume":"112","author":"Huang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_25","first-page":"4738","article-title":"LncRNA RP11-567G11.1 accelerates the proliferation and invasion of renal cell carcinoma through activating the Notch pathway","volume":"24","author":"Liu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nsmb1209","article-title":"The gene encoding the splicing factor SF2\/ASF is a proto-oncogene","volume":"14","author":"Karni","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41420-021-00498-w","article-title":"SRSF1 promotes the inclusion of exon 3 of SRA1 and the invasion of hepatocellular carcinoma cells by interacting with exon 3 of SRA1pre-mRNA","volume":"7","author":"Lei","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_30","unstructured":"Cancer Genome Atlas Research Network (2017). Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 169, 1327\u20131341."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1093\/bioinformatics\/btt495","article-title":"CatRAPID omics: A web server for large-scale prediction of protein-RNA interactions","volume":"29","author":"Agostini","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","article-title":"JASPAR 2022: The 9th release of the open-access database of transcription factor binding profiles","volume":"50","author":"Rauluseviciute","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: Still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s11033-024-09694-0","article-title":"Canonical WNT\/\u03b2-catenin signaling upregulates aerobic glycolysis in diverse cancer types","volume":"51","author":"Rathee","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Pajak, B., Siwiak, E., So\u0142tyka, M., Priebe, A., Zieli\u0144ski, R., Fokt, I., Ziemniak, M., Ja\u015bkiewicz, A., Borowski, R., and Domoradzki, T. (2019). 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010234"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e2504054","DOI":"10.1002\/advs.202504054","article-title":"SNORA74A Drives Self-Renewal of Liver Cancer Stem Cells and Hepatocarcinogenesis Through Activation of Notch3 Signaling","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1111\/jcmm.15317","article-title":"MicroRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.celrep.2017.02.016","article-title":"MiR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling","volume":"18","author":"Pinna","year":"2017","journal-title":"Cell Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/s41388-024-03157-3","article-title":"The tumor suppressor Parkin exerts anticancer effects through regulating mitochondrial GAPDH activity","volume":"43","author":"Sun","year":"2024","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: Molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s11658-023-00438-9","article-title":"Deciphering STAT3 signaling potential in hepatocellular carcinoma: Tumorigenesis, treatment resistance, and pharmacological significance","volume":"28","author":"Hashemi","year":"2023","journal-title":"Cell. Mol. Biol. Lett."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/15\/1350\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:31:22Z","timestamp":1785313882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/15\/1350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":43,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cells15151350"],"URL":"https:\/\/doi.org\/10.3390\/cells15151350","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}